SOUTHBOROUGH, Mass., April 25, 2011 /PRNewswire/ —
SynapDx Corporation announced today that Thomas Mac Mahon
has joined its board of directors.
Thomas Mac Mahon was President and Chief Executive Officer and a
member of the Executive and Management Committees of Laboratory
Corporation of America (LabCorp) from January 1997 until his
retirement at the end of 2006. Prior to LabCorp, Mr. Mac Mahon was
Senior Vice President of Hoffmann-La Roche Inc. (Roche) from 1993
to December 1996 and President of Roche Diagnostics Group from 1988
to December 1996.
Mr. Mac Mahon currently serves on the board of directors of
LabCorp. He was Chairman of the Board of Directors of LabCorp from
April 1996 until May 2009. He is currently a director of Express
Scripts, Inc. and a member of the board of PharMerica
Corporation.
About SynapDx Corporation
SynapDx’s mission is to provide laboratory testing services to
physicians who evaluate children for developmental disorders with
the initial goal of enabling earlier detection of autism. Autism
Spectrum Disorders are currently estimated to affect 1 in 110
children in the United States according to the Centers for Disease
Control.
SynapDx was founded by Stanley Lapidus and closed a Series A
round of venture funding in May 2010 from North Bridge Venture
Partners, Bain Capital Ventures and General Catalyst Partners.
SynapDx’s corporate headquarters is located in Southborough, MA.
For more information, please visit: www.synapdx.com.
‘/>”/>
SOURCE
